Reducing depressive symptomatology with a smartphone app: study protocol for a randomized, placebo-controlled trial
Open accessThe DOI matches its Crossref record; 56 of the 58 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Depression has become one of the leading contributors to the global disease burden. Evidence-based treatments for depression are available, but access to them is still limited in some instances. As technology has become more integrated into mental health care, computerized cognitive behavioral therapy (CBT) protocols have become available and have been recently transposed to mobile environments (e.g., smartphones) in the form of "apps." Preliminary research on some depression apps has shown promising results in reducing subthreshold or mild to moderate depressive symptoms. However, this small number of studies reports a low statistical power and they have not yet been replicated. Moreover, none of them included an active placebo comparison group. This is problematic, as a "digital placebo effect" may explain some of the positive effects documented until now. The aim of this study is to test a newly developed mobile app firmly grounded in the CBT theory of depression to determine whether this app is clinically useful in decreasing moderate depressive symptoms when compared with an active placebo. Additionally, we are interested in the app's effect on emotional wellbeing and depressogenic cognitions. METHODS/DESIGN: Romanian-speaking adults (18 years and older) with access to a computer and the Internet and owning a smartphone are included in the study. A randomized, three-arm clinical trial is being conducted (i.e., active intervention, placebo intervention and delayed intervention). Two hundred and twenty participants with moderate depressive symptoms (i.e., obtaining scores >9 and ≤16 on the Patient Health Questionnaire, PHQ-9) will be randomized to the three conditions. Participants undergoing therapy, presenting serious mental health problems, or legal or health issues that would prevent them from using the app, as well as participants reporting suicidal ideation are excluded. Participants randomized to the active and placebo interventions will use the smartphone app for 6 weeks. A short therapist check-in via phone will take place every week. Participants in the delayed-intervention condition will be given access to the app after 6 weeks from randomization. The primary outcome is the level of depressive symptomatology. The intervention delivered through the app to the active condition includes psychoeducational materials and exercises based on CBT for depression, while the placebo intervention uses a sham version of the app (i.e., similar structure of courses and exercises). DISCUSSION: To our knowledge, this study protocol is the first to test the efficacy of a smartphone app for depressive symptomatology in the form of a randomized controlled trial (RCT) that includes an active placebo condition. As such, this can substantially add to the body of evidence supporting the use of apps designed to decrease depression. TRIAL REGISTRATION: ClinicalTrials.gov, identifier: NCT03060200 . Registered on 1 February 2017. The first participant was enrolled on 17 February 2017.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



![Fig. 4 Consolidated Standards of Reporting Trials (CONSORT) flow diagram [25] showing subject allocation to the study conditions](https://figures.cochat.ai/paper-figures/5b84f71c7a0246ecb556f49151c3cd69/reducing-depressive-symptomatology-with-a-smartphone-app-study-protocol-for-a-figure-4.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Several recent protocols include a placebo intervention (a sham version of the app) [53]; unfortunately, only some of the studies assessed in the included meta-review involved such placebo app control.”
From Mobile Apps for Mental Health Issues: Meta-Review of Meta-Analyses (2020) · cites this paper as [53]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Faul, F., Erdfelder, E., Lang, A.-G., & Buchner, A. (2007) · Behavior Research Methods · doi:10.3758/bf03193146 · Cited by 65,971 · cited 1×
“An a priori sample size calculation was conducted with G*Power 3.1.9.2 [58, 59] for analysis of variance (ANOVA) (repeated measures, be-tween factors), assuming an alpha level of 0.05, a statistical power of 0.80, and a small to medium effect size ( f = 0.2).”
MethodInfluentialThe CES-D Scale: A Self-Report Depression Scale for Research in the General Population
Radloff, L. S. (1977) · Applied Psychological Measurement · doi:10.1177/014662167700100306 · Cited by 53,267 · cited 1×
“The level of depressive symptomatology is assessed with the Center for Epidemiologic Studies Depression Scale – Revised (CESD-R) [37, 38].”
MethodThe PHQ-9: Validity of a brief depression severity measure
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2001.016009606.x · Cited by 44,910
Statistical power analyses using G∗Power 3.1: tests for correlation and regression analyses
Faul, F., Erdfelder, E., Buchner, A., & Lang, A.-G. (2009) · Behavior Research Methods · doi:10.3758/brm.41.4.1149 · Cited by 37,615 · cited 1×
“An a priori sample size calculation was conducted with G*Power 3.1.9.2 [58, 59] for analysis of variance (ANOVA) (repeated measures, be-tween factors), assuming an alpha level of 0.05, a statistical power of 0.80, and a small to medium effect size ( f = 0.2).”
MethodInfluentialDevelopment and validation of brief measures of positive and negative affect: The PANAS scales.
Watson, D., Clark, L. A., & Tellegen, A. (1988) · Journal of Personality and Social Psychology · doi:10.1037/0022-3514.54.6.1063 · Cited by 32,433 · cited 1×
“The Positive and Negative Affect Scale (PANAS) [40] is a 20-item self-report questionnaire designed to assess mood.”
BackgroundThe satisfaction with life scale
Diener, E., Emmons, R. A., Larsen, R. J., & Griffin, S. (1985) · Journal of Personality Assessment · doi:10.1207/s15327752jpa4901_13 · Cited by 31,768 · cited 1×
“Satisfaction with Life (SWL) [43] is a five-item scale designed to measure global cognitive judgments of one ’ s life satisfaction.”
BackgroundCONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
the CONSORT Group, Schulz, K. F., Altman, D. G., & Moher, D. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-18 · Cited by 13,371
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
Schulz, K. F., Altman, D. G., Moher, D., & for the CONSORT Group (2010) · BMJ · doi:10.1136/bmj.c332 · Cited by 9,329
SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials
Chan, A.-W., Tetzlaff, J. M., Altman, D. G., Laupacis, A., Gøtzsche, P. C., Krleža-Jerić, K., Hróbjartsson, A., Mann, H., Dickersin, K., Berlin, J. A., et al. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-3-201302050-00583 · Cited by 7,363 · cited 1×
“…of Reporting Trials (CON-SORT) guidelines [25] and the Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) Statement 2013 [26] are followed (see also Additional file 1: SPIRIT 2013 Checklist: recommended items to address in a clinical trial protocol and related documents).”
(1975) · Medical Entomology and Zoology · Cited by 7,245
Research works printed but not linked: 1
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition: DSM-IV-TR®. Washington: American Psychiatric Pub; 2000.
Cited by
Mobile Apps for Mental Health Issues: Meta-Review of Meta-Analyses
Lecomte, T., Potvin, S., Corbière, M., Guay, S., Samson, C., Cloutier, B., Francoeur, A., Pennou, A., & Khazaal, Y. (2020) · JMIR mHealth and uHealth · doi:10.2196/17458 · Cited by 336
“Several recent protocols include a placebo intervention (a sham version of the app) [53]; unfortunately, only some of the studies assessed in the included meta-review involved such placebo app control.”
BackgroundSmartphone Apps for the Treatment of Mental Disorders: Systematic Review
Miralles, I., Granell, C., Díaz-Sanahuja, L., Van Woensel, W., Bretón-López, J., Mira, A., Castilla, D., & Casteleyn, S. (2020) · JMIR mHealth and uHealth · doi:10.2196/14897 · Cited by 188
“7Cups [160], Be Good to Yourself [18], BlueWatch [161], Dcombat [162], Get Happy Program [163], HeadGear [164], iCare Prevent [165], MedLink [166], Mobile Sensing and Support [167], MoodHacker [168], Moodivate [169], MyGamePlan [170], PRIME-D [171], Push-D [172], SocioEmpathy [173], SPSRS [174], SuperBetter [175], The…”
BackgroundKumar, V., Sattar, Y., Bseiso, A., Khan, S., & Rutkofsky, I. H. (2017) · Cureus · doi:10.7759/cureus.1626 · Cited by 105
“[1] 2017/England Reducing depressive symptomatology with a smart phone app: study protocol for a randomized, placebo-controlled trial Trials Moderate depression One of the first active study protocols to involve an active digital placebo group”
BackgroundMethodInfluentialHuman Support in App-Based Cognitive Behavioral Therapies for Emotional Disorders: Scoping Review
Bernstein, E. E., Weingarden, H., Wolfe, E. C., Hall, M. D., Snorrason, I., & Wilhelm, S. (2022) · Journal of Medical Internet Research · doi:10.2196/33307 · Cited by 54
“No No Giosan et al, 2017 [41] 1 DCombat”
BackgroundRecent developments in the use of smartphone interventions for mental health
Mehrotra, S., & Tripathi, R. (2018) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000439 · Cited by 45
Metadata
- Authors
- Giosan, C., Cobeanu, O., Mogoaşe, C., Szentagotai, A., Mureşan, V., & Boian, R.
- Affiliations
- Berkeley College (US)
- Babeș-Bolyai University (RO)
- Corresponding author
- Giosan, Cezar
- Venue
- Trials
- Published
- 2017-05-12
- Volume
- 18
- Issue
- 1
- Pages
- 215-215
- ISSN
- 1745-6215 (ISSN-L)
- PMC
- PMC5427551
- OpenAlex
- W2612511966
- Cited by
- 23
- References
- 58
- Citations by year
- 2025: 2 · 2023: 3 · 2022: 4 · 2021: 2 · 2020: 4 · 2019: 4 · 2018: 3 · 2017: 1
- FWCI
- 3.76
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Trials (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- EEA Grants (EEA-JRP-RO-NO-2013-1-0358.)
- Topics
- Social Sciences › Psychology › Applied Psychology › Digital Mental Health Interventions
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
- Keywords
- depression, mobile application, digital mental health interventions, active placebo, depressive symptoms, emotional well-being, psychoeducation, PHQ-9, access to mental health care, delayed intervention
- MeSH terms
- Smartphone, Affect, Clinical Protocols, Cognition, Depression, Emotions, Health Services Accessibility, Humans, Health Knowledge, Attitudes, Practice, Patient Education as Topic, Psychiatric Status Rating Scales, Surveys and Questionnaires, Research Design, Romania, Therapy, Computer-Assisted, Time Factors, Cognitive Behavioral Therapy, Treatment Outcome, Mobile Applications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Reducing depressive symptomatology with a smartphone app: study protocol for a randomized, placebo-controlled trial. https://app.cochat.ai/papers/10.1186/s13063-017-1960-1
- The paper
- Giosan, C., Cobeanu, O., Mogoaşe, C., Szentagotai, A., Mureşan, V., & Boian, R. (2017). Reducing depressive symptomatology with a smartphone app: study protocol for a randomized, placebo-controlled trial. Trials. https://doi.org/10.1186/s13063-017-1960-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.